INmune Bio Market Cap

INmune Bio has a market cap or net worth of $68.06 million as of August 14, 2025. Its market cap has decreased by -58.80% in one year.

Market Cap

68.06M

Enterprise Value

35.14M

1-Year Change

-58.80%

Ranking

#4382

Market Cap Chart

Since February 4, 2019, INmune Bio's market cap has decreased from $77.82M to $68.06M, a decrease of -12.55%. That is a compound annual growth rate of -2.03%.

Market Cap History

Date	Market Cap	% Change
Aug 13, 2025	68.06M	-34.27%
Dec 31, 2024	103.55M	-48.97%
Dec 29, 2023	202.92M	78.35%
Dec 30, 2022	113.78M	-37.49%
Dec 31, 2021	182.00M	-21.41%
Dec 31, 2020	231.57M	270.69%
Dec 31, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	592.95B
Johnson & Johnson	420.06B
AbbVie	355.91B
UnitedHealth Group	246.17B
AstraZeneca	240.81B
Novartis AG	234.72B
Novo Nordisk	227.37B
Abbott Laboratories	225.22B

Market Cap Rankings